Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome

Next Previous
Trial Profile

A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Obinutuzumab (Primary) ; Diphenhydramine; Diphenhydramine; Methylprednisolone; Mycophenolate mofetil; Paracetamol; Prednisone
  • Indications Nephrotic syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms INShore
  • Sponsors Roche

Most Recent Events

  • 03 Apr 2025 Planned End Date changed from 15 Aug 2026 to 15 Sep 2026.
  • 03 Apr 2025 Planned primary completion date changed from 15 Aug 2026 to 15 Sep 2025.
  • 04 Oct 2024 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top